Therefore, therapy with ERAs could potentially be beneficial in obesity to reduce the risk of sequelae such as atherosclerosis, especially in young individuals where ETA-R expression is higher than in older individuals, as shown in our work. Here, EDNRA is linked to obesity disorder.